Search results
‘New era of growth’: FTSE 100 giant Astrazeneca aims to double revenue
CityAM via Yahoo Finance UK· 57 minutes agoLondon-listed Astrazeneca reported revenue of $45.8bn in 2023 and growth of 19 per cent to $12.7bn...
AstraZeneca lays out plans to hit $80bn in revenues by 2030
ShareCast· 2 hours agoAstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of...
AstraZeneca targets $80bn in yearly revenues by 2030
This Is Money· 33 minutes agoAstraZeneca is targeting $80billion in annual revenues by 2030, supported by the launch of 20 new medicines. Britain's largest pharmaceutical business achieved $45.8billion ...
AstraZeneca aims to boost revenues to $80bn by 2030
Proactive Financial News· 6 hours agoAstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch of 20 new medicines and growth in its...
Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
Yahoo Finance UK· 33 minutes ago“We delivered consistent, profitable growth yet again in Q3 and look forward to executing against...
AstraZeneca announces a billion-dollar cancer plant in Singapore
EuroNews· 18 hours agoPharmaceutical giant AstraZeneca is to open a $1.5 billion (€1.38 billion) cancer manufacturing...
BUSINESS LIVE: AZN eyes $80bn in sales; Kingfisher big ticket squeeze
This Is Money· 2 hours agoLondon-listed stocks are trading lower this morning, tracking weakness in Asian markets as US...
FTSE 100 Live 21 May: AstraZeneca sets bold revenue target, index down
Evening Standard via Yahoo Finance UK· 47 minutes agoAccording to arch remainers, one of the many things that would go south if we left the EU was our...
AstraZeneca Aims for $80 Billion in Sales by 2030
Bloomberg· 3 hours agoHave a confidential tip for our reporters? AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance UK· 18 hours agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...